Obesity, and resultant health hazards which include @entity6 , @entity65 and @entity209 , are worldwide medical problems. Control of diet and exercise are cornerstones of the management of excess weight. Foods with a low glycemic index may reduce the risk of @entity6 and @entity299 as well as their complications. As an alternative to a low glycemic index diet, there is a growing body of research into products that slow the absorption of @entity3363 through the inhibition of enzymes responsible for their digestion. These products include alpha-amylase and glucosidase inhibitors. The common white bean ( @entity11297 ) produces an alpha-amylase inhibitor, which has been characterized and tested in numerous clinical studies. A specific and proprietary product named Phase 2   Carb Controller (Pharmachem Laboratories, Kearny, NJ) has demonstrated the ability to cause @entity353 with doses of 500 to 3000 mg per day, in either a single dose or in divided doses. Clinical studies also show that Phase 2 has the ability to reduce the post-prandial spike in blood @entity413 levels. Experiments conducted incorporating Phase 2 into food and beverage products have found that it can be integrated into various products without losing activity or altering the appearance, texture or taste of the food. There have been no serious side effects reported following consumption of Phase 2. Gastro-intestinal side effects are rare and diminish upon extended use of the product. In summary, Phase 2 has the potential to induce @entity353 and reduce spikes in blood sugar caused by @entity3363 through its alpha-amylase inhibiting activity.

A proprietary alpha-amylase inhibitor from white bean ( XXXX ): a review of clinical studies on @entity353 and glycemic control.

@entity11297 :: ('3885', 'Species') :: ['Phaseolus vulgaris'] @entity353 :: ('MESH:D015431', 'Disease') :: ['weight loss'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose'] @entity65 :: ('MESH:D002318', 'Disease') :: ['cardiovascular disease'] @entity299 :: ('MESH:D006331', 'Disease') :: ['heart disease'] @entity209 :: ('MESH:D008659', 'Disease') :: ['metabolic syndrome'] @entity3363 :: ('MESH:D002241', 'Chemical') :: ['carbohydrates']
@entity11297 :: (3885,Species) :: ['Phaseolus vulgaris']
